What you need to know about health coverage for new weight loss drugs
Many American companies are dealing with health insurance coverage issues for workers when it comes to GLP-1 weight loss drugs.…
Eli Lilly and company
In this fast-paced bull market, we are increasing our Club price targets by 4 stocks
It's been difficult to keep up. That's the story of this year's big stock winners. They keep winning and winning…
What Eli Lilly Investors Can Learn from the Slow Launch of a Rival Drug
Club holding company Eli Lilly hopes to win approval for its Alzheimer's treatment in the coming weeks, but investors looking…
Why We Would Consider Buying More Eli Lilly Stock If It Were Down
Every weekday, the CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here's a…
Medicare Drug Price Negotiations: Judge Dismisses PhRMA Lawsuit
Activists protest prescription drug pricing in front of the U.S. Department of Health and Human Services (HHS) building on October…
Novo Nordisk and Eli Lilly address supply issues
In this photo illustration, injectable pens of the weight loss drug Wegovy from Novo Nordisk are shown in Oslo, Norway,…
Wall Street gives Eli Lilly and GE Healthcare well-deserved price target hikes
Wall Street liked what it saw from GE Healthcare and Eli Lilly in their earnings reports, leading to a round…
GE Healthcare (GEHC) Stock Finally Gets Some Respect After Q4 Earnings
Business at GE Healthcare Technologies closed 2023 on a strong note despite continued concerns about China. That, along with management's…
Eli Lilly's Weight Loss Drug May Treat Fatty Liver Disease
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is displayed in New York City, U.S., on December 11,…
Why Wall Street Analysts Think Big Tech Stocks Will Take a Breath
Every weekday, the CNBC Investing Club with Jim Cramer hosts a livestream of the “morning meeting” at 10:20 a.m. ET.…